PT  - JOURNAL ARTICLE
AU  - Cahan, Amos
AU  - Gottesman, Tamar
AU  - Katz, Michal Tzuchman
AU  - Masad, Roee
AU  - Azulay, Gal
AU  - Dicker, Dror
AU  - Zeidman, Aliza
AU  - Berkov, Evgeny
AU  - Levin, Gal sahaf
AU  - Tadmor, Boaz
AU  - Lev, Shaul
TI  - Development and validation of a knowledge-driven risk calculator for critical illness in COVID-19 patients
AID  - 10.1101/2020.06.14.20103754
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.14.20103754
4099  - http://medrxiv.org/content/early/2020/06/16/2020.06.14.20103754.short
4100  - http://medrxiv.org/content/early/2020/06/16/2020.06.14.20103754.full
AB  - Facing the rapidly spreading novel coronavirus disease (COVID-19), evidence to inform decision-making at both the clinical and policy-making level is highly needed. Based on the results of a study by Petrilli et al, we have developed a calculator using patient data at admission to predict the risk of critical illness (intensive care unit admission, use of mechanical ventilation, discharge to hospice, or death).We report a retrospective validation of the risk calculator on 145 consecutive patients admitted with COVID-19 to a single hospital in Israel. Of the 18 patients with critical illness, 17 were correctly identified by the model(sensitivity: 94.4%, 95% CI, 72.7% to 99.9%; specificity: 81.9%, 95% CI, 74.1% to 88.2%). Of the 127 patients with non-critical illness, 104 were correctly identified. This, despite considerable differences between the original and validation study populations.Our results show that data from published knowledge can be used to provide reliable, patient level, automated risk assessment, potentially reducing the cognitive burden on physicians and helping policy makers better prepare for future needs.Competing Interest StatementAC,RM,GA,and MZK are employed by Kahun Medical Ltd.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved and informed consent waived by the Rabin Medical Center Institutional Review Board (ref. 0339-20-RMC). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAccess to the data used in this study is restricted